DIMERx honors the memory of Peter Barton Hutt, a distinguished attorney, scholar and longtime leader in food and drug law who served as a member of the DIMERx Board of Directors.
Widely regarded as the “father of modern food and drug law,” Peter served as Chief Counsel of the U.S. Food and Drug Administration from 1971 to 1975 and played a central role in transforming the FDA into a modern regulatory agency. Among his many contributions, he helped establish the FDA’s Over-the-Counter (OTC) Drug Review and monograph system, creating a regulatory framework under which qualifying nonprescription medicines can be marketed without individual premarket approval when they meet established standards for ingredients, uses, dosing, labeling and other requirements. He also played an important role in the development of modern nutrition labeling and numerous other FDA regulatory policies that continue to influence public health and the life sciences industry today.
Peter’s influence extended well beyond his tenure at the FDA. Over a career spanning more than six decades at Covington & Burling LLP, he worked extensively with Congress on landmark food, drug and healthcare legislation. His contributions included work on the Drug Price Competition and Patent Term Restoration Act of 1984, commonly known as the Hatch-Waxman Act, which established the modern pathway for approval of generic drugs while providing patent-term protections for innovative medicines. He also contributed to legislation including the Medical Device Amendments, Prescription Drug User Fee Act and FDA Modernization Act. Earlier in his career, his work on addiction policy included drafting legislation that helped establish the National Institute on Alcohol Abuse and Alcoholism and the National Institute on Drug Abuse.
Peter was also a dedicated educator and scholar. For more than 30 years, he taught Food and Drug Law at Harvard Law School and was the lead co-author of Food and Drug Law: Cases and Materials, a foundational text in the field. His contributions to regulatory law and public health influenced generations of attorneys, regulators, scientists and life sciences leaders.
As a member of the DIMERx Board, Peter brought extraordinary regulatory expertise, intellectual rigor and thoughtful counsel to the company. We are grateful for his guidance, generosity and support of DIMERx and its mission. His contributions to our company and to the broader life sciences community will be remembered with great appreciation.
